Item 2.02. Results of Operations and Financial Conditions.

On November 10, 2022, Viveve Medical, Inc. (the "Company") issued a press release announcing its results for the fiscal quarter ended September 30, 2022. A copy of the Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such a filing, except as shall be expressly set forth by specific reference in such a filing.


--------------------------------------------------------------------------------

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits

Exhibit
  No.     Description

99.1        Press Release issued by the Company
          on November 10, 2022, announcing
          results for the fiscal quarter ended
          September 30, 2022.
104       Cover Page Interactive Data File
          (embedded within the Inline XBRL
          document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses